Erlend B Smeland

Bilde av Erlend B Smeland
English version of this page
Telefon +47-22500730
Mobiltelefon +47-91388199
Brukernavn
Besøksadresse Ullernchausseen 70 None 0372 OSLO
Postadresse Postboks 4950 Nydalen 0424 OSLO

Faglige interesser

Lymfomcellenes oppførsel

Øke kunnskap om lymfomcellene for å utvikle nye diagnostiseringsmetoder, og på sikt utvikle nye medisiner for å bedre lymfekreft behandlingen.

Undervisning

Deltatt i forberedelsesarbeidet for ny PBL refor ved Universitetet i Oslo (Oslo 96)

Undervist i PBL ved UiO siden 1999

Bakgrunn

Akademiske grader:

1980 Cand. med., Universitetet i Oslo

1987 PhD, Universitetet i oslo

1998 Professor II i eksperimentel hematologi / stamcelle transplantasjon

2009 Forskningsdirektør ved Oslo universitetssykehus i forskning, utdanning og innovasjon

 

 

 

Emneord: Lymfon, Geneforandring, stamcelle

Publikasjoner

  • Våtsveen, Thea Kristin; Myhre, Marit Renee; Steen, Chloe Beate; Wälchli, Sébastien; Lingjærde, Ole Christian; Bai, Baoyan; Dillard, Pierre; Theodossiou, Theodossis; Holien, Toril; Sundan, Anders; Inderberg, Else Marit; Smeland, Erlend B; Myklebust, June & Oksvold, Morten Pedersen (2018). Artesunate shows potent anti-tumor activity in B-cell lymphoma. Journal of Hematology & Oncology.  ISSN 1756-8722.  11:23, s 1- 12 . doi: 10.1186/s13045-018-0561-0
  • Bollum, Lise Kristin; Huse, Kanutte; Oksvold, Morten Pedersen; Bai, Baoyan; Hilden, Vera Irene; Forfang, Lise; Yoon, So; Wälchli, Sébastien; Smeland, Erlend B & Myklebust, June (2017). BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5. PLoS ONE.  ISSN 1932-6203.  12(5) . doi: 10.1371/journal.pone.0177188 Fulltekst i vitenarkiv.
  • Josefsson, Sarah Elisabet Göthberg; Huse, Kanutte; Kolstad, Arne; Beiske, Klaus; Pende, Daniela; Steen, Chloe Beate; Inderberg, Else Marit; Lingjærde, Ole Christian; Østenstad, Bjørn; Smeland, Erlend B; Levy, Ronald; Irish, Jonathan M. & Myklebust, June (2017). T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clinical Cancer Research.  ISSN 1078-0432.  24(4), s 870- 881 . doi: 10.1158/1078-0432.CCR-17-2337 Fulltekst i vitenarkiv.
  • Scott, David W.; Abrisqueta, Pau; Wright, George W.; Slack, Graham W.; Mottok, Anja; Villa, Diego; Jares, Pedro; Rauert-Wunderlich, Hilka; Royo, Cristina; Clot, Guillem; Pinyol, Magda; Boyle, Merrill; Chan, Fong Chun; Braziel, Rita M.; Chan, Wing C.; Weisenburger, Dennis D.; Cook, James R.; Greiner, Timothy C.; Fu, Kai; Ott, German; Delabie, Jan; Smeland, Erlend B; Holte, Harald; Jaffe, Elaine S.; Steidl, Christian; Connors, Joseph M.; Gascoyne, Randy D.; Rosenwald, Andreas; Staudt, Louis M.; Campo, Elias & Rimsza, Lisa M. (2017). New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies. Journal of Clinical Oncology.  ISSN 0732-183X.  35(15), s 1668- 1677 . doi: 10.1200/JCO.2016.70.7901
  • Blaker, Yngvild Nuvin; Spetalen, Signe; Eide, Marianne Brodtkorb; Lingjærde, Ole Christian; Beiske, Klaus; Østenstad, Bjørn; Sander, Birgitta; Wahlin, Björn Engelbrekt; Melen, Christopher Michael; Myklebust, June; Holte, Harald; Delabie, Jan & Smeland, Erlend B (2016). The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. British Journal of Haematology.  ISSN 0007-1048.  175(1), s 102- 114 . doi: 10.1111/bjh.14201
  • Blaker, Yngvild Nuvin; Brodtkorb, Marianne; Maddison, John; Hveem, Tarjei Sveinsgjerd; Nesheim, John Arne; Mohn, Hans Martin; Kolstad, Arne; Geisler, Christian H.; Liestøl, Knut; Smeland, Erlend B; Holte, Harald; Delabie, Jan & Danielsen, Håvard Emil (2015). Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma. Histopathology.  ISSN 0309-0167.  67(1), s 62- 69 . doi: 10.1111/his.12624
  • Fiskvik, Idun Hege; Beiske, Klaus; Delabie, Jan; Yri, Olav Erich; Spetalen, Signe; Karjalainen-Lindsberg, Marja-Liisa; Leppä, Sirpa; Liestøl, Knut; Smeland, Erlend B & Holte, Harald (2015). Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma. Leukemia and Lymphoma.  ISSN 1042-8194.  56(6), s 1742- 1749 . doi: 10.3109/10428194.2014.970550
  • Oksvold, Morten Pedersen; Duyvestyn, Johanna M.; Dagger, Samantha A.; Taylor, Samuel J.; Forfang, Lise; Myklebust, June; Smeland, Erlend B & Langdon, Wallace Y. (2015). The targeting of human and mouse B lymphocytes by dasatinib. Experimental Hematology.  ISSN 0301-472X.  43(5), s 352- 363.e4 . doi: 10.1016/j.exphem.2015.01.008
  • Riihijärvi, Sari; Fiskvik, Idun Hege; Taskinen, Minna; Vajavaara, Heli; Tikkala, Maria; Yri, Olav Erich; Karjalainen-Lindsberg, Marja-Liisa; Delabie, Jan; Smeland, Erlend B; Holte, Harald & Leppä, Sirpa (2015). Prognostic influence of macrophages in patients with diffuse large B-Cell lymphoma: A correlative study from a nordic phase ii trial. Haematologica.  ISSN 0390-6078.  100(2), s 238- 245 . doi: 10.3324/haematol.2014.113472
  • Wise, Jillian Frances; Nakken, Sigve; Vodak, Daniel; Trøen, Gunhild; Lingjærde, Ole Christian; Meza-Zepeda, Leonardo A; Myklebost, Ola; Beiske, Klaus; Myklebust, June Helene; Hovig, Eivind; Smeland, Erlend B & Holte, Harald (2015). Discovery of recurrent mutations associated with chemo-immunotherapy relapse in diffuse large B-cell lymphoma. Blood.  ISSN 0006-4971.  126(23), s 110- 110

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:44 - Sist endret 8. juni 2011 13:21